Pediatric emergency and critical care
Pediatric emergency and critical care
![Foto de Pediatric emergency and critical care](/img/grupo.png)
![Foto de Dalhousie University](/img/noimage_org.png)
Dalhousie University
Halifax, CanadáPublications in collaboration with researchers from Dalhousie University (8)
2024
-
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 78, Núm. 6, pp. 1732-1744
-
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial
The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107
2023
-
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age
The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302
2021
-
Association of Rare CYP39A1 Variants with Exfoliation Syndrome Involving the Anterior Chamber of the Eye
JAMA - Journal of the American Medical Association, Vol. 325, Núm. 8, pp. 753-764
-
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial
Vaccine, Vol. 39, Núm. 11, pp. 1598-1608
2020
-
Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial
Vaccine, Vol. 38, Núm. 8, pp. 2095-2104
-
Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial
Vaccine, Vol. 38, Núm. 8, pp. 2105-2114
2016
-
Meeting report: Harmonization of RSV therapeutics - from design to performance
Journal of Global Health, Vol. 6, Núm. 1